Suppr超能文献

基于与混合DNA的高度平行基因分型的遗传关联来鉴定人类次要组织相容性抗原。

Identification of human minor histocompatibility antigens based on genetic association with highly parallel genotyping of pooled DNA.

作者信息

Kawase Takakazu, Nannya Yasuhito, Torikai Hiroki, Yamamoto Go, Onizuka Makoto, Morishima Satoko, Tsujimura Kunio, Miyamura Koichi, Kodera Yoshihisa, Morishima Yasuo, Takahashi Toshitada, Kuzushima Kiyotaka, Ogawa Seishi, Akatsuka Yoshiki

机构信息

Division of Immunology, Aichi Cancer Center Research Institute, Nagoya, Japan.

出版信息

Blood. 2008 Mar 15;111(6):3286-94. doi: 10.1182/blood-2007-10-118950. Epub 2008 Jan 4.

Abstract

Minor histocompatibility (H) antigens are the molecular targets of allo-immunity responsible both for the development of antitumor effects and for graft-versus-host disease (GVHD) in allogeneic hematopoietic stem cell transplantation (allo-HSCT). However, despite their potential clinical use, our knowledge of human minor H antigens is largely limited by the lack of efficient methods of their characterization. Here we report a robust and efficient method of minor H gene discovery that combines whole genome association scans (WGASs) with cytotoxic T-lymphocyte (CTL) assays, in which the genetic loci of minor H genes recognized by the CTL clones are precisely identified using pooled-DNA analysis of immortalized lymphoblastoid cell lines with/without susceptibility to those CTLs. Using this method, we have successfully mapped 2 loci: one previously characterized (HMSD encoding ACC-6), and one novel. The novel minor H antigen encoded by BCL2A1 was identified within a 26 kb linkage disequilibrium block on chromosome 15q25, which had been directly mapped by WGAS. The pool size required to identify these regions was no more than 100 individuals. Thus, once CTL clones are generated, this method should substantially facilitate discovery of minor H antigens applicable to targeted allo-immune therapies and also contribute to our understanding of human allo-immunity.

摘要

次要组织相容性(H)抗原是同种免疫的分子靶点,在异基因造血干细胞移植(allo-HSCT)中既负责抗肿瘤效应的产生,也与移植物抗宿主病(GVHD)有关。然而,尽管它们具有潜在的临床应用价值,但我们对人类次要H抗原的了解在很大程度上受到缺乏有效鉴定方法的限制。在此,我们报告了一种强大而有效的次要H基因发现方法,该方法将全基因组关联扫描(WGASs)与细胞毒性T淋巴细胞(CTL)检测相结合,其中通过对永生化淋巴母细胞系进行混合DNA分析,精确鉴定CTL克隆识别的次要H基因的遗传位点,这些细胞系对CTL有/无敏感性。使用这种方法,我们成功定位了2个位点:一个是先前已鉴定的(编码ACC-6的HMSD),另一个是新发现的。由BCL2A1编码的新型次要H抗原在15q25染色体上一个26 kb的连锁不平衡区域内被鉴定出来,该区域已通过WGAS直接定位。鉴定这些区域所需的样本量不超过100个个体。因此,一旦产生CTL克隆,这种方法应能极大地促进适用于靶向同种免疫治疗的次要H抗原的发现,并有助于我们对人类同种免疫的理解。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验